Genelux (GNLX) Stock Price

Genelux Price

NASDAQ·CLOSED
2.55USD-0.41 (-14.88 %)
Market closed

Revenue at Genelux has contracted by 91.0% per year over the past 3 years to 8,000.00 USD. Genelux's net margin stands at -401,812.5%, down from -47.0% several years earlier. Analysts set a median price target of 18.36 USD, implying 620.0% above the current price. Of 12 analysts, 11 rate the stock a buy — an overall Buy consensus. The stock trades about 11% above its 52-week low.

Genelux stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Genelux over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Genelux stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Genelux's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Genelux Stock Price History
DateGenelux Price
8/5/20262.55 USD
8/4/20262.96 USD
8/3/20262.98 USD
7/31/20262.94 USD
7/30/20263.05 USD
7/29/20262.90 USD
7/27/20262.89 USD
7/23/20262.96 USD
7/22/20262.96 USD
7/21/20262.89 USD
7/20/20262.93 USD
7/17/20262.87 USD
7/16/20262.82 USD
7/15/20262.91 USD
7/14/20262.89 USD
7/13/20263.00 USD
7/10/20263.03 USD
7/9/20262.98 USD
7/8/20262.87 USD
7/7/20262.97 USD
7/6/20263.16 USD
7/2/20262.99 USD
7/1/20262.90 USD
6/30/20263.01 USD
6/29/20262.90 USD
6/26/20262.87 USD
6/25/20262.90 USD
6/24/20262.85 USD
6/23/20262.92 USD
6/22/20262.97 USD
6/18/20262.96 USD
6/17/20262.85 USD
6/16/20263.03 USD
6/15/20263.02 USD
6/12/20262.96 USD
6/11/20262.88 USD
6/10/20262.86 USD
6/9/20262.98 USD
6/8/20262.93 USD
6/5/20262.93 USD
6/4/20263.08 USD
6/3/20263.00 USD
6/2/20262.95 USD
6/1/20262.97 USD
5/29/20263.05 USD
5/28/20263.07 USD
5/27/20263.06 USD
5/26/20263.01 USD
5/22/20262.92 USD
5/21/20262.92 USD
5/20/20262.93 USD
5/19/20262.80 USD
5/18/20262.85 USD
5/15/20262.92 USD
5/14/20263.04 USD
5/13/20263.19 USD
5/12/20262.97 USD
5/11/20262.90 USD
5/8/20263.11 USD
5/7/20262.83 USD
5/6/20262.87 USD
5/5/20262.77 USD
5/4/20262.85 USD
5/1/20262.74 USD
4/30/20262.67 USD
4/29/20262.50 USD
4/28/20262.53 USD
4/27/20262.56 USD
4/24/20262.52 USD
4/23/20262.52 USD
4/22/20262.54 USD
4/21/20262.56 USD
4/20/20262.65 USD
4/17/20262.79 USD
4/16/20262.77 USD
4/15/20262.84 USD
4/14/20262.64 USD
4/13/20262.53 USD
4/10/20262.54 USD
4/9/20262.56 USD
4/8/20262.64 USD
4/7/20262.65 USD
4/6/20262.73 USD
4/2/20262.57 USD
4/1/20262.56 USD
3/31/20262.42 USD
3/30/20262.30 USD
3/27/20262.48 USD
3/26/20262.63 USD
3/25/20262.65 USD
3/24/20262.42 USD
3/23/20262.48 USD
3/20/20262.40 USD
3/19/20262.54 USD
3/18/20262.59 USD
3/17/20262.62 USD
3/16/20262.63 USD
3/13/20262.60 USD
3/12/20262.63 USD
3/11/20262.78 USD
3/10/20262.80 USD
3/9/20262.83 USD
3/6/20262.71 USD
3/5/20262.69 USD
3/4/20262.68 USD
3/3/20262.58 USD
3/2/20262.92 USD
2/27/20262.98 USD
2/26/20262.89 USD
2/25/20262.97 USD
2/24/20262.79 USD
2/23/20262.70 USD
2/20/20262.64 USD
2/19/20262.68 USD
2/18/20262.62 USD
2/17/20262.56 USD
2/13/20262.61 USD
2/12/20262.49 USD
2/11/20262.42 USD
2/10/20262.42 USD
2/9/20262.46 USD
2/6/20262.39 USD
2/5/20262.35 USD
2/4/20262.58 USD
2/3/20262.72 USD
2/2/20262.73 USD
1/30/20262.66 USD
1/29/20262.74 USD
1/28/20262.76 USD
1/27/20262.96 USD
1/26/20262.85 USD
1/23/20262.87 USD
1/22/20262.88 USD
1/21/20262.83 USD
1/20/20262.73 USD
1/16/20262.74 USD
1/15/20262.56 USD
1/14/20262.61 USD
1/13/20262.74 USD
1/12/20262.65 USD
1/9/20262.80 USD
1/8/20262.72 USD
1/7/20263.39 USD
1/6/20263.39 USD
1/5/20263.48 USD
1/2/20264.55 USD
12/31/20254.36 USD
12/30/20254.34 USD
12/29/20254.38 USD
12/26/20254.37 USD
12/24/20254.40 USD
12/23/20254.34 USD
12/22/20254.37 USD
12/19/20254.20 USD
12/18/20254.19 USD
12/17/20254.15 USD
12/16/20254.10 USD
12/15/20254.08 USD
12/12/20254.31 USD
12/11/20254.40 USD
12/10/20254.51 USD
12/9/20254.55 USD
12/8/20254.37 USD
12/5/20254.64 USD
12/4/20254.65 USD
12/3/20254.65 USD
12/2/20254.73 USD
12/1/20254.90 USD
11/28/20255.56 USD
11/26/20255.59 USD
11/25/20255.29 USD
11/24/20255.10 USD
11/21/20254.96 USD
11/20/20254.64 USD
11/19/20255.00 USD
11/18/20255.06 USD
11/17/20255.25 USD
11/14/20255.32 USD
11/13/20255.51 USD
11/12/20255.93 USD
11/11/20255.98 USD
11/10/20255.89 USD
11/7/20255.42 USD
11/6/20255.30 USD
11/5/20257.84 USD
11/4/20258.11 USD
11/3/20258.24 USD
10/31/20258.08 USD
10/30/20257.96 USD
10/29/20257.70 USD
10/28/20257.64 USD
10/27/20257.30 USD
10/24/20257.82 USD
10/23/20257.71 USD
10/22/20256.31 USD
10/21/20256.72 USD
10/20/20256.51 USD
10/17/20255.72 USD
10/16/20255.36 USD
10/15/20255.44 USD
10/14/20255.28 USD
10/13/20255.25 USD
10/10/20255.07 USD
10/9/20255.67 USD
10/8/20254.75 USD
10/7/20254.71 USD
10/6/20254.54 USD
10/3/20254.45 USD
10/2/20254.39 USD
10/1/20254.40 USD
9/30/20254.20 USD
9/29/20254.25 USD
9/26/20254.20 USD
9/25/20254.21 USD
9/24/20254.37 USD
9/23/20254.34 USD
9/22/20254.11 USD
9/19/20254.16 USD
9/18/20254.01 USD
9/17/20253.91 USD
9/16/20254.09 USD
9/15/20253.92 USD
9/12/20253.95 USD
9/11/20253.65 USD
9/10/20253.65 USD
9/9/20253.67 USD
9/8/20253.56 USD
9/5/20253.37 USD
9/4/20253.48 USD
9/3/20253.31 USD
9/2/20253.37 USD
8/29/20253.33 USD
8/28/20253.53 USD
8/27/20253.64 USD
8/26/20253.79 USD
8/25/20253.74 USD
8/22/20253.78 USD
8/21/20253.44 USD
8/20/20253.36 USD
8/19/20253.43 USD
8/18/20253.54 USD
8/15/20253.56 USD
8/14/20253.41 USD
8/13/20253.20 USD
8/12/20253.19 USD
8/11/20253.28 USD
8/8/20253.15 USD
Access this data via the Eulerpool API
Get Free API Key

Genelux Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
170,000.00 USD
-27.48 M USD
-28.30 M USD
Jan 1, 2024
8,000.00 USD
-31.70 M USD
-29.87 M USD
Jan 1, 2025
8,000.00 USD
-33.21 M USD
-32.15 M USD
Jan 1, 2026 (e)
0.00 USD
-39.75 M USD
-36.44 M USD
Jan 1, 2027 (e)
12.18 M USD
-38.45 M USD
-34.07 M USD
Jan 1, 2028 (e)
90.21 M USD
-10.54 M USD
-2.89 M USD
Jan 1, 2029 (e)
185.67 M USD
33.14 M USD
54.12 M USD
Jan 1, 2030 (e)
303.69 M USD
93.28 M USD
152.32 M USD

Genelux Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 8, 2026, 12:17 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20192020202120222023202420252026e2027e2028e2029e2030e
–––11.00––––12.0090.00185.00303.00
–––––––––650.00105.5663.78
–––90.91––––90.9190.9190.9190.91
10.0010.0010.0010.0010.0010.0010.0010.0010.9181.82168.18275.45
-10.00-12.00-14.00-2.00-27.00-31.00-33.00-39.00-38.00-10.0033.0093.00
–––-18.18––––-316.67-11.1117.8430.69
-11.00-14.00-17.00-5.00-28.00-29.00-32.00-36.00-34.00-2.0054.00152.00
–27.2721.43-70.59460.003.5710.3412.50-5.56-94.12-2,800.00181.48
37.1823.6531.2824.5526.7931.4537.1837.1837.1837.1837.1837.18
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Genelux generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Genelux retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Genelux's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Genelux has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Genelux's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Genelux stock margins

The Genelux margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genelux. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genelux.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
-7,075.00 %
- %
- %
Jan 1, 2022
91.25 %
-24.39 %
-47.05 %
Jan 1, 2023
-498.82 %
-16,161.77 %
-16,645.29 %
Jan 1, 2024
-11,187.50 %
-396,199.98 %
-373,362.48 %
Jan 1, 2025
-7,075.00 %
-415,175.00 %
-401,812.48 %
Jan 1, 2026 (e)
-7,075.00 %
- %
- %
Jan 1, 2027 (e)
-7,075.00 %
-315.61 %
-279.67 %
Jan 1, 2028 (e)
-7,075.00 %
-11.69 %
-3.20 %

Genelux Stock Revenue, EBIT, Earnings per Share

The Genelux earnings per share therefore indicates how much revenue Genelux has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
0.00 USD
-0.47 USD
-0.57 USD
Jan 1, 2022
0.45 USD
-0.11 USD
-0.21 USD
Jan 1, 2023
0.01 USD
-1.03 USD
-1.06 USD
Jan 1, 2024
0.00 USD
-1.01 USD
-0.95 USD
Jan 1, 2025
0.00 USD
-0.89 USD
-0.86 USD
Jan 1, 2026 (e)
0.00 USD
-1.07 USD
-0.82 USD
Jan 1, 2027 (e)
0.27 USD
-1.03 USD
-0.76 USD
Jan 1, 2028 (e)
2.02 USD
-0.28 USD
-0.06 USD

Genelux business model & stock analysis

Genelux Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Genelux Employees
Details
Date
Genelux Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Genelux Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Genelux historical P/E ratio, EBIT multiple, and P/S ratio

Genelux annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Genelux shares outstanding

The number of shares of Genelux was 37.18 M in 2025. This indicates how many shares Genelux is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
31.28 M Stocks
Jan 1, 2022
24.55 M Stocks
Jan 1, 2023
26.79 M Stocks
Jan 1, 2024
31.45 M Stocks
Jan 1, 2025
37.18 M Stocks
Jan 1, 2026 (e)
37.18 M Stocks
Jan 1, 2027 (e)
37.18 M Stocks
Jan 1, 2028 (e)
37.18 M Stocks

Current Genelux forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
91.67 % (11)
Hold
8.33 % (1)
Sell
0.00 % (0)
12M Price Target
18.36
Last Price
2.70
Currency
USD
12M Return Potential
580.00 %
LTM Return
0 %

Genelux Analyst Rating Actions

DateFirmActionRatingReliability
3/20/2026
Benchmark
Benchmark
MaintainedSpeculative Buy71
5/8/2025
Benchmark
Benchmark
MaintainedSpeculative Buy71
3/31/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
3/25/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
11/15/2024
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
8/15/2024
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
6/3/2024
Benchmark
Benchmark
MaintainedSpeculative Buy71
5/31/2024
Benchmark
Benchmark
MaintainedSpeculative Buy71
5/13/2024
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
4/3/2024
Benchmark
Benchmark
MaintainedSpeculative Buy71

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Genelux Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/3/2026-0.20USD-0.00USD-2026 Q2
5/13/2026-0.18USD-0.00USD-2026 Q1
4/6/2026-0.22USD-0.00USD-2025 Q4
8/11/2025-0.21USD-0.00USD-2025 Q2
11/12/2024-0.19USD-0.00USD-2024 Q3

EESG©

Eulerpool ESG Scorecard© for the Genelux stock

56/100
56
Environment
85
Social
26
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Genelux shareholder structure

% Name
7.09351%
Szalay (Aladar)
Szalay (Aladar)
4.12458%
Woodward Diversified Capital, LLC
Woodward Diversified Capital, LLC
3.25172%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.59696%
Bleichroeder LP
Bleichroeder LP
1.46116%
Zindrick (Thomas)
Zindrick (Thomas)
1.12454%
Thomas (John)
Thomas (John)
...

Genelux Beneficial Ownership Filings (SEC 13D/G)

Free Float
80.6%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
9.99%
Armistice Capital, LLC
Armistice Capital, LLC
SEC ↗
8.70%
Billy James Parrott
Billy James Parrott
SEC ↗
8.20%
Aladar Szalay
Aladar Szalay
SEC ↗
6.80%
Highbridge Capital Management, LLC
Highbridge Capital Management, LLC
SEC ↗

Genelux Executives and Management Board

12 members · avg. age 65 · 8 % women

TZ

Mr. Thomas Zindrick (66)

Chairman of the Board, President, Chief Executive Officer · since 2014

1.47 M USD

Management

JC

Dr. Joseph Cappello (68)

Chief Technical Officer

601,814.00 USD
MP

Mr. Matthew Pulisic (41)

Chief Financial Officer

–
TY

Dr. Tony Yu (54)

Senior Vice President - Clinical Development

–
EG

Mr. Eric Groen (54)

General Counsel, Corporate Secretary, Chief Compliance Officer, Head of Business Development

–
PS

Dr. Paul Scigalla (80)

Chief Medical Officer

–
RS

Mr. Ralph Smalling (69)

Head - Regulatory

–

Board of Directors

JS

Mr. John Smither (72)

Independent Director

231,500.00 USD
JT

Mr. James Tyree (72)

Lead Independent Director

225,000.00 USD
JT

Dr. John Thomas (67)

Independent Director

219,000.00 USD
MM

Ms. Mary Mirabelli (68)

Independent Director

215,500.00 USD

Frequently asked questions about Genelux

Analysts currently set an average price target of 19.72 USD for the Genelux stock (median: 18.36 USD), implying +630.4 % versus the latest price. The consensus is based on 12 analyst ratings.

Genelux Analyst Price Targets 2026

12 analysts currently rate the Genelux stock: 11 recommend buying, 1 holding and 0 selling.

Genelux Analyst Price Targets 2026

Converted at the current exchange rate, the Genelux share trades at 2.21 EUR (2.55 USD).

The Genelux share (GNLX) is listed on 1 stock exchanges, including: NASDAQ (GNLX).

No history available for Genelux.

The revenue cannot currently be calculated for Genelux.

The expected profit of Genelux is -36.44 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Genelux is currently -2.60. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genelux stock.

The P/S cannot be calculated for Genelux currently.

The Eulerpool Quality Score for Genelux is 2/10.

The ISIN of Genelux is US36870H1032. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Genelux is GNLX. The ticker symbol is used to trade Genelux shares on the stock exchange.

Genelux paid dividends every year for the past 0 years.

Genelux is assigned to the 'Health' sector.

The dividends of Genelux are distributed in USD.

All fundamentals and in-depth analysis of Genelux

Our stock analysis for Genelux stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genelux. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Genelux Stock
Genelux Revenue→
Genelux Stock
Genelux Net Income→
Genelux Stock
Genelux P/E→
Genelux Stock
Genelux P/S→
Genelux Stock
Genelux EBIT→
Genelux Stock
Genelux Dividend→
Genelux Stock
Genelux Directors Dealings→
Genelux Stock
Genelux Stocks→
Genelux Stock
Genelux Market capitalization→
Genelux Stock
Genelux Debt→
Genelux Stock
Genelux Liabilities→
Genelux Stock
Genelux Equity→
Genelux Stock
Genelux AAQS→
Genelux Stock
Genelux Employees→
Genelux Stock
Genelux ROE→
Genelux Stock
Genelux ROA→
Genelux Stock
Genelux ROCE→
Genelux Stock
Genelux News→
Genelux Stock
Genelux Analyst Price Targets→

Health Stocks

GenematrixGenelinkGenenta Science SpA ADRGeneDx HoldingsGeneral BiologicalsGenedriveGeneReach BiotechnologyGeneBioTech CoGenertec Universal Medical Group CoGene One Life ScienceGenesis Fertility Center PCLGencurixAll Stocks A–Z →